OBJECTIVE: Learning and memory impairments are prevalent among persons with multiple sclerosis (MS); however, such deficits are only weakly associated with MS disease severity (brain atrophy). The cognitive reserve hypothesis states that greater lifetime intellectual enrichment lessens the negative impact of brain disease on cognition, thereby helping to explain the incomplete relationship between brain disease and cognitive status in neurologic populations. The literature on cognitive reserve has focused mainly on Alzheimer disease. The current research examines whether greater intellectual enrichment lessens the negative effect of brain atrophy on learning and memory in patients with MS. METHODS: Forty-four persons with MS completed neuropsychological measures of verbal learning and memory, and a vocabulary-based estimate of lifetime intellectual enrichment. Brain atrophy was estimated with third ventricle width measured from 3-T magnetization-prepared rapid gradient echo MRIs. Hierarchical regression was used to predict learning and memory with brain atrophy, intellectual enrichment, and the interaction between brain atrophy and intellectual enrichment. RESULTS: Brain atrophy predicted worse learning and memory, and intellectual enrichment predicted better learning; however, these effects were moderated by interactions between brain atrophy and intellectual enrichment. Specifically, higher intellectual enrichment lessened the negative impact of brain atrophy on both learning and memory. CONCLUSION: These findings help to explain the incomplete relationship between multiple sclerosis disease severity and cognition, as the effect of disease on cognition is attenuated among patients with higher intellectual enrichment. As such, intellectual enrichment is supported as a protective factor against disease-related cognitive impairment in persons with multiple sclerosis.
OBJECTIVE:Learning and memory impairments are prevalent among persons with multiple sclerosis (MS); however, such deficits are only weakly associated with MS disease severity (brain atrophy). The cognitive reserve hypothesis states that greater lifetime intellectual enrichment lessens the negative impact of brain disease on cognition, thereby helping to explain the incomplete relationship between brain disease and cognitive status in neurologic populations. The literature on cognitive reserve has focused mainly on Alzheimer disease. The current research examines whether greater intellectual enrichment lessens the negative effect of brain atrophy on learning and memory in patients with MS. METHODS: Forty-four persons with MS completed neuropsychological measures of verbal learning and memory, and a vocabulary-based estimate of lifetime intellectual enrichment. Brain atrophy was estimated with third ventricle width measured from 3-T magnetization-prepared rapid gradient echo MRIs. Hierarchical regression was used to predict learning and memory with brain atrophy, intellectual enrichment, and the interaction between brain atrophy and intellectual enrichment. RESULTS:Brain atrophy predicted worse learning and memory, and intellectual enrichment predicted better learning; however, these effects were moderated by interactions between brain atrophy and intellectual enrichment. Specifically, higher intellectual enrichment lessened the negative impact of brain atrophy on both learning and memory. CONCLUSION: These findings help to explain the incomplete relationship between multiple sclerosis disease severity and cognition, as the effect of disease on cognition is attenuated among patients with higher intellectual enrichment. As such, intellectual enrichment is supported as a protective factor against disease-related cognitive impairment in persons with multiple sclerosis.
Authors: D A Bennett; R S Wilson; J A Schneider; D A Evans; C F Mendes de Leon; S E Arnold; L L Barnes; J L Bienias Journal: Neurology Date: 2003-06-24 Impact factor: 9.910
Authors: Ralph H B Benedict; Jared M Bruce; Michael G Dwyer; Nadir Abdelrahman; Sarah Hussein; Bianca Weinstock-Guttman; Neeta Garg; Frederick Munschauer; Robert Zivadinov Journal: Arch Neurol Date: 2006-09
Authors: Ralph H B Benedict; Bianca Weinstock-Guttman; Inna Fishman; Jitendra Sharma; Christopher W Tjoa; Rohit Bakshi Journal: Arch Neurol Date: 2004-02
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: Francesco Patti; Maria Pia Amato; Maria Trojano; Stefano Bastianello; Maria Rosalia Tola; Orietta Picconi; Sabina Cilia; Salvatore Cottone; Luigi M E Grimaldi Journal: Qual Life Res Date: 2011-09-28 Impact factor: 4.147
Authors: Carolyn E Schwartz; Wesley Michael; Jie Zhang; Bruce D Rapkin; Mirjam A G Sprangers Journal: Qual Life Res Date: 2017-09-06 Impact factor: 4.147
Authors: Aaron Bonner-Jackson; Jeffrey D Long; Holly Westervelt; Geoffrey Tremont; Elizabeth Aylward; Jane S Paulsen Journal: J Int Neuropsychol Soc Date: 2013-05-23 Impact factor: 2.892
Authors: Helen M Genova; Jeannie Lengenfelder; Nancy D Chiaravalloti; Nancy B Moore; John DeLuca Journal: Appl Neuropsychol Adult Date: 2012 Impact factor: 2.248
Authors: James F Sumowski; Maria A Rocca; Victoria M Leavitt; Jelena Dackovic; Sarlota Mesaros; Jelena Drulovic; John DeLuca; Massimo Filippi Journal: Neurology Date: 2014-04-18 Impact factor: 9.910
Authors: Menno M Schoonheim; René M Vigeveno; Fernanda C Rueda Lopes; Petra J W Pouwels; Chris H Polman; Frederik Barkhof; Jeroen J G Geurts Journal: Hum Brain Mapp Date: 2013-08-24 Impact factor: 5.038